T0	Participants 42 65	after vaginal delivery:
T1	Participants 163 186	after vaginal delivery.
T2	Participants 226 312	patients between 22 weeks and 42 weeks of gestation with anticipated vaginal delivery.
T3	Participants 794 852	a total of 1,604 patients would be required in each group.
T4	Participants 861 984	A total of 848 patients were enrolled and 756 randomly assigned, 377 in the misoprostol group and 379 in the placebo group.
T5	Participants 985 1074	Demographic, antepartum, and intrapartum characteristics were similar between the groups.